155 results
Page 3 of 8
8-K
EX-4.1
pvttcqq627hp
6 Aug 21
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-10.1
ut7c68uq 34
6 Aug 21
Entry into a Material Definitive Agreement
4:50pm
8-K
EX-4.2
pyo tw6jw9e3sqamo5mc
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
xj7xlhjc3tk9i
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
adn0wm3e7ttuanev5p
19 May 21
Entry into a Material Definitive Agreement
12:00am
8-K/A
EX-99.2
hbg115t9lble64g
20 Apr 21
Report of Independent Registered Public Accounting Firm
5:18pm
8-K/A
EX-99.1
qxul2emmkzz 0opf136
20 Apr 21
Report of Independent Registered Public Accounting Firm
5:18pm
8-K
EX-10.1
lmswk
20 Apr 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.2
16e43ouw53
20 Apr 21
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-10.1
wsbns9
22 Sep 20
Entry into a Material Definitive Agreement
12:00am
DEFM14C
dbtckuh m9
31 Aug 20
Information related to merger
7:00am
8-K/A
EX-99.1
gc803qtn1o qh36u0gw8
19 Aug 20
Report of Independent Registered Public Accounting Firm
5:06pm
PREM14C
zgr56jnb17wha5b
19 Aug 20
Preliminary information related to merger
4:41pm
8-K
y89sav ghbtk5rr
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.1
lmvgsh12s 9rgg
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-10.5
e4ru gvv3fh83o26
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-10.6
167jti8o
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
8-K
EX-3.2
wnzrsh3z
11 Jun 20
OncBioMune Announces Closing of Asset Purchase Agreement with Avant Diagnostics
5:27pm
SC 14F1
qtl3y
8 Jun 20
Statement regarding change in majority of directors
11:05am